Form 8-K - Current report:
SEC Accession No. 0001628280-26-042525
Filing Date
2026-06-11
Accepted
2026-06-11 16:32:54
Documents
14
Period of Report
2026-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20260609.htm   iXBRL 8-K 53734
2 EX-10.1 pacira2014amendedandrestat.htm EX-10.1 87119
3 EX-99.1 exhibit991-agmpressrelease.htm EX-99.1 15411
7 PACIRA BIOSCIENCES LOGO pacirabiosciencestmrgb.jpg GRAPHIC 468777
  Complete submission text file 0001628280-26-042525.txt   897184

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20260609.xsd EX-101.SCH 1792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20260609_lab.xml EX-101.LAB 21880
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20260609_pre.xml EX-101.PRE 12518
18 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20260609_htm.xml XML 2831
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 261083605
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)